Clinical Trial Feasibility, Site Selection and Site Setup Services
Site Selection and Site Setup for Phase I, Phase II and Phase III Clinical Trials
TCR-Solutions provides clinical trial site selection and site setup services designed to support early phase studies while scaling effectively across Phase I, Phase II, and Phase III clinical trials.
Our approach is built on a clear operational principle:
👉 Sites must recruit — not just participate.
We combine data-led feasibility with direct investigator engagement, ensuring that site selection reflects real-world patient access, investigator motivation, and protocol fit. This is particularly important in early phase studies, where timelines are compressed, and in Phase III trials, where consistency and scalability across multiple sites determines success.
Our Clinical Trial Site Selection and Site Setup services include:
• Targeted investigator and site identification using validated databases and therapeutic expertise
• Feasibility assessments grounded in real recruitment capability, not just historical participation
• Site Qualification Visits (SQVs) with structured capability and performance scoring
• Contract and budget negotiation
• Essential document collection and eTMF readiness, ensuring inspection-ready standards
• Coordination with Clinical Trial Regulatory Affairs Services for UK, EU, and global submissions
• IMP supply readiness and pharmacy coordination
• Site Initiation Visits (SIVs) and investigator training
• End-to-end activation tracking, integrated with Clinical Trial Project Management.
We work closely with Clinical Study Monitoring & CRA Services to ensure sites remain engaged, compliant, and productive throughout the study lifecycle.
Our Site Selection and Setup approach is strengthened by the experience of our founder and COO, Davy Yeung, whose extensive background managing hospital research departments provides a deep understanding of local site processes and the practical realities of study delivery at the site level.
Why Site Selection Matters In Clinical Trials
Across Phase I, Phase II, and Phase III clinical trials, site performance is one of the most significant drivers of:
• Recruitment timelines
• Data quality
• Overall study cost
In many studies, delays are not caused by protocol complexity alone, but by site selection strategies that prioritise availability over delivery capability. Our site selection and setup model supports:
• Faster, more predictable site activation timelines
• Improved recruitment performance across sites
• Reduced screen failure and patient drop-out rates
• Greater consistency in data quality across study sites
By integrating site selection with Protocol Design, Regulatory Affairs, Project Management, and Monitoring, we provide a joined-up delivery model with global reach, supporting programmes from first-in-human through to Phase III.
Frequently Asked Questions
Do you support Phase III clinical trials?
Yes — we support site selection and site setup services across Phase I, Phase II and Phase III clinical trials, including global and multicentre studies.
How do you improve recruitment outcomes?
Because we know the UK, European, and US site landscapes so intimately, we guide sponsors toward locations that have the best infrastructure for long-term data collection, focusing on sites with high-quality electronic records.
Can you support global site strategies?
Yes — as a UK CRO with global reach, we support both UK and international clinical trial site selection strategies.